Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression data of the livers of male C57Bl6/N mice after i.p. injection of paracetamol (APAP)

ABSTRACT: Male C57BL6/N mice were obtained from Janvier Labs (France). Mice were starved overnight before APAP administration and were fed ad libitum afterward. A single dose of 300 mg APAP/kg b.w. was intraperitoneally injected in warm phosphate-buffered saline (PBS; Table 3). The used APAP was obtained from Sigma-Aldrich (A7085-500G, Germany). The mice were sacrificed at 1, 6, and 12 hours, and on days 1, 2, 4, 6, and 8 after APAP administration. Expression data of the livers of male C57Bl6/N mice after intoxication with paracetamol (APAP)

ORGANISM(S): Mus musculus

PROVIDER: GSE167032 | GEO | 2021/06/30

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Expression data of the livers of male C57Bl6/N mice after i.p. injection of paracetamol (APAP)

Project description:Expression data of the livers of male C57Bl6/N mice after i.p. injection of paracetamol (APAP)

| PRJNA702769 | ENA

Next Generation Sequencing timecourse of murine hepatocytes with or without paracetamol treatment

Project description:Untreated mice or mice treated with paracetamol, in the presence or absence of TSA, were culled after 14 hrs or 24 hrs of treatment, and RNAseq was performed. Method: RNA was extracted, in triplicate, then sequenced with an Illumina NextSeq 500 sequencer. Sequence reads passing the quality control filters were aligned using Tophat2 and then analysed with Cufflinks.

2020-06-30 | GSE132368 | GEO

Transcription profiling time series toxicogenomic profiles in CD-1 mice after nontoxic and nonlethal hepatotoxic paracetamol administration

Project description:Effect of vehicle vs non-toxic and toxic paracetamol (151mg/kg and 529mg/kg) doses on the gene expression profile at 1, 4 and 24h in murine liver.

2004-02-20 | E-MEXP-82 | biostudies-arrayexpress

Generic drug screen identifies paracetamol as 5-aza-2’-deoxycytidine sensitizer in head and neck squamous cell carcinoma cells

Project description:Aberrant DNA methylation (5mC) is one of the key characteristics of many cancers including head and neck squamous cell carcinoma (HNSCC). The DNA demethylating agent 5-aza-2’-deoxycytidine (DAC) has anti-cancer therapeutic potential, but its clinical efficacy is currently hindered by dose-limiting side effects. Here we investigated the potential use of DAC in the treatment of HNSCC and show that its efficacy is primarily dependent on the ability of DAC to demethylate DNA. In order to establish whether HNSCC cells can be sensitized to DAC, a panel of 100 generic drugs were screened in combination with DAC. While the 100-drug panel did not sensitise DAC-resistant HNSCC cell lines to DAC treatment, the screen identified that paracetamol (acetaminophen), valproic acid and zinc acetate significantly enhanced DAC efficacy in the DAC-responsive cell lines. DAC and paracetamol were established to work in synergy, allowing DAC to be used at therapeutically relevant low doses (below 500nM). The mechanisms underlying the DAC-paracetamol synergy are multifactorial and encompass both effects of DAC on paracetamol action (alterations in the cyclooxygenase (COX) pathway and mimicry of paracetamol overdose) as well as decreased DNA methylation by paracetamol. Therefore, we propose DAC to be a potential therapeutic in a subset of HNSCC patients with its efficacy significantly increased by use of the common analgesic paracetamol. The DAC-paracetamol synergy should also be considered in cancers with an approved DAC treatment regime.

2018-11-02 | GSE110045 | GEO

Single-cell ATAC-seq analysis of hESCs undergoing neuronal differentiation exposed to paracetamol [scATAC-seq]

Project description:Genome-wide chromatin opening profiling of hESCs undergoing neuronal differentiation at four distinct time-points. hESCs are differentiated using a neuronal protocol, and day 20 were charachterized. Cells exposed to 100 or 200 μM paracetamol from Day 1.

2023-08-31 | GSE220026 | GEO

Shifted Metabolic Bias in Livers of Mice Lacking Hepatocytic Thioredoxin Reductase-1 Protects Against Acetaminophen Toxicity

Project description:Genetic disruption of thioredoxin reductase 1 protects against acetaminophen (APAP) toxicity. To determine the role of the thioredoxin system on xenobiotic metabolism we challeneged wildtype and txnrd1liver-null mice with acetaminophen. Adult male wildtype and txnrd1 liver-null mice (C57BL6/J) were treated with either saline (PBS) or 100mg/kg APAP. Liver RNA was harvested eight hours after challenge and processed for microarray analysis. Comparison of 2 treatment conditions in 2 genotypes, biological replicates in triplicate.

2013-06-08 | E-GEOD-37874 | biostudies-arrayexpress

Gene expression analysis of hESCs undergoing neuronal differentiation exposed to paracetamol [RNA-seq]

Project description:Genome-wide gene expression profiling of hESCs undergoing neuronal differentiation at four distinct time-points. hESCs are differentiated using a neuronal differentiation protocol, day 7 and 20 were charachterized. Cells were exposed to 100 or 200 μM paracetamol from Day 1 were charachterised at Day 7 and Day 20.

2023-08-31 | GSE220024 | GEO

Epigenome analysis of hESCs undergoing neuronal differentiation in presence or absence of paracetamol [MethylationEPIC BeadChip]

Project description:Genome wide DNA methylation profiling of human embryonic stem cells (hESCs) at day 0, and day 7, 13 and 20 of neuronal differentiation. Cells were exposed to paracetamol from Day 1 and onwards. The Illumina Infinium MethylationEPIC_v-1-0_B3 was used to obtain DNA methylation profiles accross approximately 850k CpGs in differentiating cells.

2023-08-31 | GSE220023 | GEO

Single-cell gene expression analysis of hESCs undergoing neuronal differentiation upon exposure to paracetamol [scRNA-seq]

Project description:Single-cell RNA-seq of hESCs undergoing neuronal differentiation at four distinct time-points. hESCs are differentiated using a novel protocol, and day 0, 7, 13 and 20 were charachterized. Cells exposed to 100 or 200 μM paracetamol from Day 1 were charachterised at Day 7 and Day 20.

2023-08-31 | GSE220025 | GEO

Effect of paracetamol in gastrointestinal cancer surgery

Project description:Intervention 1: Intervention group: every 6 hours up to a maximum weight based on grams (total dose 24 h 4 grams) Paracetamol IV to receive. If a patient requires drug for pain or analgesic PRN 0.5mg/kg, up to a maximum ceiling of 35 mg to receive. Intervention 2: Control group: patients, 0.5mg/kg every 6 hours, up to a maximum of 50 mg analgesic receives and the need for additional drug fixed dose of 35 mg intravenously has analgesic.;Treatment - Drugs;Treatment - Drugs;Intervention group: every 6 hours up to a maximum weight based on grams (total dose 24 h 4 grams) Paracetamol IV to receive. If a patient requires drug for pain or analgesic PRN 0.5mg/kg, up to a maximum ceiling of 35 mg to receive.;Control group: patients, 0.5mg/kg every 6 hours, up to a maximum of 50 mg analgesic receives and the need for additional drug fixed dose of 35 mg intravenously has analgesic. Primary outcome(s): Reduce pain. Timepoint: Three days after surgery. Method of measurement: VAS. Study Design: Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: This study was double blinded.At sampling time Patient and information collector were not aware of which group they would be and patients randomly divided in 2 groups, base on their folder numbers. The study designer was inform about drugs administration.

| 2479199 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data